OP-130: USE OF POINT-OF-CARE TESTING TO ASSESS OPTIMAL ANTIPLATELET THERAPY WHEN A NASOGASTRIC TUBE IS THE ONLY WAY OF ADMINISTRATION

2011 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []